A Brush-On Cavity Treatment Passed Its Big U.S. Trial — and Why That Matters in Cancer Care

What the headline says

Headlines this week describe a liquid that stops cavities in seconds, with no drill, no needle and no sedation. The liquid is real, it is decades old, and a large U.S. trial has now tested it properly. It is worth understanding what was measured, because the study looked at toddlers' baby teeth — not at the mouths of people going through cancer treatment, where tooth decay can become a serious problem.

What the trial actually did

The treatment is silver diamine fluoride, usually shortened to SDF. A dentist paints it onto a cavity with a small sponge-tipped applicator. It does not remove any tooth material. The goal is not to repair the hole but to arrest it — to stop the decay getting deeper.

Researchers led by the University of Michigan, with New York University and the University of Iowa, ran a phase III randomized trial funded by the National Institute of Dental and Craniofacial Research. Some details worth knowing:

• 830 children, aged 12 to 71 months, all with severe early childhood tooth decay and active, open cavities.
• Randomized and blinded, with a placebo. 414 children received 38% SDF; 416 received a placebo — deionized water tinted with blue dye, so neither families nor examiners could easily tell the arms apart. That placebo arm is what makes this result stronger than the observational evidence that came before it.
• Two applications, at the start and again at six months.
• The main result, at six months: 54.0% of treated cavities had stopped (95% confidence interval 43.1% to 64.6%), compared with 22.5% in the placebo group. That is a difference of about 31 percentage points. At eight months the figures were 50.2% and 17.4%.
• Side effects were common in both groups and mostly mild: 47.3% of the SDF group and 43.3% of the placebo group reported any adverse event. Four severe events were recorded across the trial (0.6%).
• The trial stopped early. According to the registry record, an interim analysis met the pre-set stopping rules, so no new children were enrolled after that point. Children already taking part finished their visits.

One drawback is permanent and visible: silver turns the decayed part of the tooth black. That matters more to some families than to others, and it is a conversation to have before treatment, not after.

What this does not mean

• It does not mean cavities no longer need dentists. Roughly half the treated cavities were arrested. The other half were not, and a stopped cavity is still a hole in a tooth that a dentist needs to watch.
• It does not mean SDF is now an approved cavity treatment. In the United States, SDF is cleared as a device for tooth sensitivity and has been used off-label for decay since 2014. The investigators say these data are intended to support a future application to the Food and Drug Administration. Nothing about its legal status changed this week.
• It was not studied in people with cancer. Every participant was a young child with baby teeth. The trial says nothing directly about adults after radiation to the head and neck, about children being treated for leukemia, or about permanent teeth.
• It is not a home remedy. SDF is applied by a dental professional. There is no version of this you buy and paint on yourself.

Why a cavity story belongs on a cancer site

Tooth decay is not a footnote in cancer care. The National Cancer Institute's patient guidance on oral complications is direct about it: radiation to the head and neck can damage the salivary glands, and those glands "may not recover completely after radiation therapy ends." Less saliva changes the balance of bacteria in the mouth, and NCI notes that both together "increase the risk of tooth decay." Fluoride gel at bedtime is part of standard advice for exactly this reason.

There is a second problem. NCI also warns that "oral surgery or other dental work can cause problems in patients who have had radiation therapy to the head or neck." So the group most likely to develop rapid decay is also the group for whom the usual fix — drilling, filling, extracting — carries added risk. A treatment that arrests decay without touching the tooth is, at least in principle, aimed at that gap.

At least in principle. Researchers have studied SDF in adults with radiation-related decay, but this trial is not that evidence, and we are not going to pretend otherwise. What the trial does supply is a well-run placebo-controlled result showing the liquid genuinely stops decay rather than merely appearing to — which is the foundation any future use would have to be built on.

The practical takeaway for readers in treatment is older and better established than the news: get a dental check-up before treatment starts if you possibly can. NCI suggests at least a month ahead, so the mouth has time to heal from any dental work. Our guides on dental care before head and neck radiation, managing a dry mouth and mouth sores and oral care during treatment cover what that visit usually involves, and whether a cleaning is safe mid-chemotherapy covers the timing question people ask most.

Questions to ask a healthcare team

• Should I see a dentist before my cancer treatment starts, and how soon?
• Is my treatment likely to cause dry mouth, and if so, is it likely to be temporary or lasting?
• What daily fluoride or mouth-care routine do you recommend for me?
• If I develop a cavity during or after treatment, what are my options besides drilling — and is silver diamine fluoride one my dentist would consider?
• Who should my dentist speak to on my oncology team before doing any dental work?

A trial like this is a good reminder that the small, unglamorous parts of care — teeth, saliva, a check-up scheduled a month early — often decide how much pain someone lives with later. Free, plain-language explanations like this one are funded entirely by readers.